+1 (888) 794-0077
« Return

Virtual Tours Available Today

Explore our New Jersey facilities from wherever you are working, even the comfort of your own home.

Virtually tour our New Jersey facilities in Cranbury and Plainsboro to learn about our Bioanalytical and DMPK capabilities and instrumentation to support your drug discovery and development programs.

Let’s discuss how we can help you meet your goals!

Follow WuXi AppTec Laboratory Testing Division on LinkedIn for industry insights and program support.

For more information, please visit: https://labtesting.wuxiapptec.com/


As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024 and its open-access platform is enabling around 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that “every drug can be made and every disease can be treated.”

Related Posts

3 Ways Personalized Medicine is Transforming Reproductive Health

3 Ways Personalized Medicine is Transforming Reproductive Health

Personalized medicine, often referred to as precision medicine, is reshaping healthcare by tailoring treatments to the unique genetic, environmental, and lifestyle characteristics of individual patients. This approach has shown transformative potential in reproductive health, particularly in areas such as fertility treatments and developmental and reproductive toxicology (DART). 

Key Toxicology Considerations for Large-Molecule Therapies

Key Toxicology Considerations for Large-Molecule Therapies

Large molecule therapies hold immense promise for treating a range of diseases. However, developing large molecule therapies has unique challenges, particularly in preclinical testing. Toxicology studies are crucial because they provide essential data about the drug’s biological effects and safety profile.